Baseline Neutrophil Production Before Chemotherapy
Healthy marrow continuously replaces short-lived neutrophils around the clock.
- 1,500–8,000: Normal ANC range (cells per microliter)
- ~8 hrs: Neutrophil lifespan (once circulating in blood)
- ~1×10¹¹/day: Marrow output (cells produced daily)
- 10–14 days: Maturation time (stem cell to mature cell)
Steady-state marrow output keeps ANC stable
Stem cells divide constantly, replacing neutrophils lost to short lifespans.
Cytotoxic Chemotherapy Suppresses Marrow Stem Cells
Chemo targets rapidly dividing cells, hitting marrow progenitors hard.
- 24–48 hrs: Onset of myelosuppression (after infusion begins)
- Dividing: Cells hit hardest (progenitor / stem cells)
- Unaffected: Circulating cells (briefly, at first)
- Halted: New production (while drug is active)
Chemo blocks new neutrophil generation
Existing neutrophils keep circulating while replacement supply is cut off.
ANC Falls Toward the Nadir, Day 7–14
With no replacements arriving, circulating ANC drains toward its lowest point.
- Day 7–14: Typical nadir window (post-chemotherapy)
- ~150: Nadir ANC (no G-CSF) (cells per microliter)
- ~5–7 days: Neutropenia duration (below 500 cells/µL)
- None: Replacement cells (arriving during suppression)
Circulating count drains as no cells are replaced
ANC drops daily until marrow finally resumes making new neutrophils.
Fever Plus Critical ANC Signals a Medical Emergency
Low ANC with fever means infection risk is now dangerously high.
- ANC <500: High-risk threshold (cells per microliter)
- ANC <100: Critical threshold (severe neutropenia)
- ≥38.3°C: Fever definition (single oral reading)
- <1 hour: Antibiotic window (from fever onset)
Febrile neutropenia requires urgent treatment
Any fever at critical ANC triggers immediate empiric IV antibiotics.
Filgrastim Shortens the Nadir and Lowers Risk
G-CSF stimulates marrow output, shrinking the vulnerable low-ANC window.
- ~Day 6: Nadir day (with G-CSF) (vs. day 10 untreated)
- ~900: Nadir ANC (with G-CSF) (vs. ~150 untreated)
- ~50%: Febrile risk reduction (with prophylactic use)
- Bone pain: Common side effect (from marrow stimulation)
G-CSF accelerates stem cell output
Stimulated marrow shortens the dip and speeds neutrophil recovery.